Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis. Lanz TV, Becker S, Osswald M, Bittner S, Schuhmann MK, Opitz CA, Gaikwad S, Wiestler B, Litzenburger UM, Sahm F, et al. Proc Natl Acad Sci U S A. 2013 Aug 19. PMID: 23959874. Abstract CommentRecommendBookmarkWatch